Park WS - Search Results

1

Inhibition of voltage-gated potassium channel by aripiprazole in rabbit coronary arterial smooth muscle cells.

Kang M, Mun SY, Zhuang W, Park M, Jeong J, Park H, Jung WK, Choi IW, Na S, Park WS. Kang M, et al. Among authors: park ws. Eur J Pharmacol. 2024 Jun 15;973:176610. doi: 10.1016/j.ejphar.2024.176610. Epub 2024 Apr 23. Eur J Pharmacol. 2024. PMID: 38663541

2

Characterization of an alkali-extracted peptidoglycan from Korean Ganoderma lucidum.

Cheong J, Jung W, Park W. Cheong J, et al. Arch Pharm Res. 1999 Oct;22(5):515-9. doi: 10.1007/BF02979162. Arch Pharm Res. 1999. PMID: 10549581

3

Endothelin-1 acts via protein kinase C to block KATP channels in rabbit coronary and pulmonary arterial smooth muscle cells.

Park WS, Ko EA, Han J, Kim N, Earm YE. Park WS, et al. J Cardiovasc Pharmacol. 2005 Feb;45(2):99-108. doi: 10.1097/01.fjc.0000150442.49051.f7. J Cardiovasc Pharmacol. 2005. PMID: 15654257

4

Staurosporine inhibits voltage-dependent K+ current through a PKC-independent mechanism in isolated coronary arterial smooth muscle cells.

Park WS, Son YK, Han J, Kim N, Ko JH, Bae YM, Earm YE. Park WS, et al. J Cardiovasc Pharmacol. 2005 Mar;45(3):260-9. doi: 10.1097/01.fjc.0000154370.57789.fe. J Cardiovasc Pharmacol. 2005. PMID: 15725952

5

Endothelin-1 inhibits inward rectifier K+ channels in rabbit coronary arterial smooth muscle cells through protein kinase C.

Park WS, Han J, Kim N, Youm JB, Joo H, Kim HK, Ko JH, Earm YE. Park WS, et al. J Cardiovasc Pharmacol. 2005 Nov;46(5):681-9. doi: 10.1097/01.fjc.0000182846.08357.ed. J Cardiovasc Pharmacol. 2005. PMID: 16220076

6

Slowing of the inactivation of voltage-dependent sodium channels by staurosporine, the protein kinase C inhibitor, in rabbit atrial myocytes.

Ko JH, Park WS, Kim SJ, Earm YE. Ko JH, et al. Among authors: park ws. Eur J Pharmacol. 2006 Mar 18;534(1-3):48-54. doi: 10.1016/j.ejphar.2006.01.018. Epub 2006 Feb 20. Eur J Pharmacol. 2006. PMID: 16488408

7

Direct modulation of Ca(2+)-activated K(+) current by H-89 in rabbit coronary arterial smooth muscle cells.

Park WS, Son YK, Kim N, Youm JB, Warda M, Ko JH, Ko EA, Kang SH, Kim E, Earm YE, Han J. Park WS, et al. Vascul Pharmacol. 2007 Feb;46(2):105-13. doi: 10.1016/j.vph.2006.08.413. Epub 2006 Sep 8. Vascul Pharmacol. 2007. PMID: 17052962

8

The effect of tyrosine kinase inhibitor genistein on voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.

Ko EA, Park WS, Son YK, Kim DH, Kim N, Kim HK, Choi TH, Jung ID, Park YM, Han J. Ko EA, et al. Among authors: park ws, park ym. Vascul Pharmacol. 2009 Jan-Feb;50(1-2):51-6. doi: 10.1016/j.vph.2008.09.004. Epub 2008 Oct 11. Vascul Pharmacol. 2009. PMID: 18952004

9

Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases.

Jung WK, Lee DY, Park C, Choi YH, Choi I, Park SG, Seo SK, Lee SW, Yea SS, Ahn SC, Lee CM, Park WS, Ko JH, Choi IW. Jung WK, et al. Among authors: park ws, park c, park sg. Br J Pharmacol. 2010 Mar;159(6):1274-85. doi: 10.1111/j.1476-5381.2009.00615.x. Epub 2010 Jan 28. Br J Pharmacol. 2010. PMID: 20128801 Free PMC article.

10

Cilostazol protects mice against endotoxin shock and attenuates LPS-induced cytokine expression in RAW 264.7 macrophages via MAPK inhibition and NF-kappaB inactivation: not involved in cAMP mechanisms.

Park WS, Jung WK, Lee DY, Moon C, Yea SS, Park SG, Seo SK, Park C, Choi YH, Kim GY, Choi JS, Choi IW. Park WS, et al. Among authors: park c, park sg. Int Immunopharmacol. 2010 Sep;10(9):1077-85. doi: 10.1016/j.intimp.2010.06.008. Epub 2010 Jun 19. Int Immunopharmacol. 2010. PMID: 20601185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,131 results

Search Page